glp 1 and dual glp 1 gip receptor agonists Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review

Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats

27.06

★★★★☆4.8 (126)

Not all GLP medications work the same. Fat loss isn't about shortcuts. It's about using the right tools paired with training, nutrition, and accountability. Education first. Performance always. Take advantage of 50%

24.12

★★★★★4.9 (98)

I-M-150847, a novel GLP-1 and GIP receptor dual agonist, reduces body weight gain and improves glycemic control in the rodent model of type 2 diabetes and obesity

22.16

★★★★★5.0 (157)

The dual agonist action of tirzepatide on various organs. GLP-1:

27.69

★★★★★4.7 (84)

Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research

25.42

★★★★★4.9 (203)

Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care

28.89

★★★★★5.0 (176)

🔴Comparison of GLP-1R Mono-Agonist vs. Dual GIPR/GLP-1R Agonist Therapy⤵️ #2025Review 1️⃣ GLP-1 RA are well-studied, but the mechanisms of GIP receptor (GIPR) agonists remain less understood. 2️⃣ GLP-1R monotherapy (e.g., semaglutide) is

24.32

★★★★★4.8 (132)